Quantcast Adaptix | Downing



Based at Harwell Oxford, the UK’s premier Science Campus, Adaptix was one of the top European Life Sciences companies selected to present at the 2013 Tech Tour Healthcare summit; was named one of UK Trade and Investment’s Top 20 early stage health-tech companies in 2012; and was the Life Sciences winner of the European Venture Contest in 2011.

Adaptix provides technology to create a future in which low-cost X-ray solutions are fully portable with a reduced system footprint, maximising their deployment in secondary care and making them available in primary care and even to field-based users.  The company has been supported by bodies such as Innovate UK and the UK Science and Technology Facilities Council in recognition of the potential for its novel technology to transform healthcare and disrupt a global industry.

Important Notice

Investing in our products will place your capital at risk and you may not get back the full amount invested. Any tax treatment may be subject to change and the availability and value of the reliefs depend on the individual circumstances of each investor. The availability of tax reliefs also depends on the investee companies maintaining their qualifying status.

Further information can be found at HMRC’s website. Neither past performance or forecasts are reliable indicators of future results and should not be relied upon. Unquoted or smaller company shares are likely to have higher price fluctuations and are likely to be more difficult to sell than shares quoted on the London Stock Exchange Official List. Website content is not intended to constitute investment, tax or legal advice. We recommend you seek independent advice before investing in any of our products.

Important Notice

Downing’s investments place your capital at risk and you may not get back the full amount invested. Past performance and forecasts are not a reliable guide to future results. Tax treatment may be subject to change and depends on individual circumstances. Smaller company shares are likely to have higher volatility and liquidity risks than other types of main market listed instruments. We recommend that you seek professional independent financial advice before investing. We do not offer investment or tax advice.

By clicking below you confirm you have read and understood the information above.